Pure Global

Parvovirus B19 IgM - India CDSCO Medical Device Registration

Parvovirus B19 IgM is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/001078_faf9513eaf12fa66fe71e5507980734e_4d82ef4847a16a14fc6f9bc5d380f568. This device is marketed under the brand name NovaLisa®. The license holder is OSB Agencies Private Limiated, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Parvovirus B19 IgM
UID: IMP/IVD/2020/001078_faf9513eaf12fa66fe71e5507980734e_4d82ef4847a16a14fc6f9bc5d380f568

Brand Name

NovaLisa®

Device Class

Class B

Approving Authority

CDSCO

Product Information

The Parvovirus B19IgM ELISA is intended for the qualitative determination of IgM class antibodies against Parvovirus B19 in human serum or plasma (NovaLisa®)

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing